Royalty Pharma plc (RPRX)

Royalty Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,751	11,334	12,497	17,432	17,116	19,426
Market Cap Growth	-0.56%	-9.30%	-28.31%	1.85%	-11.89%	-
Enterprise Value	25,268	21,332	21,132	27,333	26,687	28,409
Last Close Price	33.35	25.34	27.06	37.12	36.75	45.42
PE Ratio	13.60	13.20	11.01	407.00	27.62	39.23
Forward PE	7.04	6.10	7.47	10.32	13.00	19.16
PS Ratio	6.55	5.01	5.31	7.79	7.48	9.15
PB Ratio	2.12	1.10	1.24	1.83	1.67	1.96
P/TBV Ratio	2.81	1.63	1.92	3.11	2.97	4.06
P/OCF Ratio	6.94	4.09	4.18	8.13	8.48	9.55
PEG Ratio	0.63	2.14	2.65	0.94	1.12	1.97
EV/Sales Ratio	11.16	9.42	8.98	12.22	11.66	13.39
EV/EBITDA Ratio	-	-	14.11	29.44	18.36	16.88
EV/EBIT Ratio	13.30	16.51	14.16	29.62	18.65	17.11
Debt / Equity Ratio	0.78	0.74	0.61	0.75	0.69	0.59
Debt / EBITDA Ratio	-	-	4.10	7.66	4.88	3.46
Asset Turnover	0.13	0.13	0.14	0.13	0.14	0.15
Quick Ratio	1.56	1.43	7.78	2.11	16.77	8.73
Current Ratio	1.56	1.44	7.90	2.19	16.81	8.76
Return on Equity (ROE)	18.00%	13.03%	17.34%	2.33%	12.32%	21.22%
Return on Assets (ROA)	7.04%	4.67%	5.62%	3.36%	5.33%	7.29%
Return on Capital (ROIC)	7.11%	4.73%	5.68%	3.39%	5.41%	7.38%
Return on Capital Employed (ROCE)	11.60%	7.60%	9.20%	5.90%	8.20%	10.60%
Earnings Yield	5.83%	7.58%	9.08%	0.25%	3.62%	5.02%
Dividend Yield	2.64%	3.31%	2.96%	2.05%	1.85%	0.66%
Payout Ratio	35.89%	43.83%	31.57%	778.21%	46.02%	40.80%
Buyback Yield / Dilution	1.86%	1.46%	-37.66%	-5.59%	-10.48%	-
Total Shareholder Return	4.50%	4.77%	-34.70%	-3.54%	-8.63%	0.66%

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q